低分子肝素在肾脏病抗凝治疗中的应用.pptVIP

  • 6
  • 0
  • 约2.57万字
  • 约 51页
  • 2023-03-30 发布于广东
  • 举报

低分子肝素在肾脏病抗凝治疗中的应用.ppt

thrombin activatable fibrinolysis inhibitor 凝血酶激活的纤溶抑制物(TAFI) TAT: 凝血酶抗凝血酶复合物 F1+2:凝血酶原片段1+2 PAP:纤维蛋白溶酶-抗纤维蛋白溶酶复合物 依诺肝素或达钠肝素单剂量注射与普通肝素标准用法比较 Comparison of effects of different heparins on thrombin activatable fibrinolysis inhibitor in hemodialyzed patients. Comparison of effects of different heparins on thrombin activatable fibrinolysis inhibitor in hemodialyzed patients. 红笔试验为使用依诺肝素的试验, 其余为达肝素钠、那屈肝素、亭扎肝素 Seventeen trials were included in this systematic review, 11 of which were included in the meta-analysis. It was found that LMWH did not significantly affect the number of bleedi

文档评论(0)

1亿VIP精品文档

相关文档